Fundz

Brainstorm Cell Therapeutics Secures $155,000 in Funding

PUBLIC · BCLINov 06, 2025

Amount Raised

$155,000

Round Type

Funding Round

New YorkBiotechnologyHealth CareTherapeuticsresearch

Investors

Vanquish Funding Group Inc.

Description

On October 31, 2025, Brainstorm Cell Therapeutics Inc entered into a securities purchase agreement with Vanquish Funding Group Inc. The agreement resulted in the issuance of a promissory note worth $182,400, from which the company received $155,000 after fees. The note is convertible into company shares under specific conditions. This funding will support the company's ongoing development of therapies for neurodegenerative diseases.

Company Information

Company

Brainstorm Cell Therapeutics

Location

1325 Avenue of Americas, 28th Floor

New York, New York, United States

About

BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI) is a leading developer of autologous adult stem cell therapies for debilitating neurodegenerative diseases. The company's proprietary NurOwn® platform uses autologous mesenchymal stem cells (MSCs) to produce neurotrophic factor-secreting cells (MSC-NTF cells), designed to deliver targeted biological signals that modulate neuroinflammation and promote neuroprotection.

Fundz sees it the moment Brainstorm Cell Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsChaim L., Chief Executive Officer hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Brainstorm Cell Therapeutics's next move

See what Strategic adds

Brainstorm Cell Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.